AI assistant
Sending…
REGENERON PHARMACEUTICALS, INC. — Director's Dealing 2021
Aug 13, 2021
29977_dirs_2021-08-13_27b06aaa-d8c0-4fe7-9f22-b39ec70d0915.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REGENERON PHARMACEUTICALS, INC. (REGN)
CIK: 0000872589
Period of Report: 2021-08-11
Reporting Person: SING GEORGE L (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-11 | Common Stock | S | 1000 | $620.0 | Disposed | 47063 | Direct |
| 2021-08-11 | Common Stock | S | 1000 | $621.0 | Disposed | 46063 | Direct |
| 2021-08-12 | Common Stock | S | 1000 | $611.0 | Disposed | 45063 | Direct |
| 2021-08-13 | Common Stock | S | 500 | $620.0 | Disposed | 44563 | Direct |
| 2021-08-11 | Common Stock | S | 300 | $620.0 | Disposed | 3050 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1150 | Indirect |
| Common Stock | 400 | Indirect |
More from REGENERON PHARMACEUTICALS, INC.
Regulatory Filings
2026
May 8
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 29
Regulatory Filings
2026
Apr 29
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3